prednisolone has been researched along with Lymphoma, T Cell, Peripheral in 47 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Haemocytopenia was the predominant adverse effect, and acute toxicity was moderate, tolerable and well managed in both arms." | 2.84 | The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers. ( Chang, Y; Duan, W; Fu, X; Li, L; Li, X; Li, Z; Nan, F; Sun, Z; Wang, X; Wu, J; Yan, J; Young, KH; Zhang, L; Zhang, M; Zhang, X, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.26) | 18.2507 |
| 2000's | 5 (10.64) | 29.6817 |
| 2010's | 31 (65.96) | 24.3611 |
| 2020's | 9 (19.15) | 2.80 |
| Authors | Studies |
|---|---|
| Lage, LAPC | 1 |
| Brito, CV | 1 |
| Barreto, GC | 1 |
| Culler, HF | 1 |
| Reichert, CO | 1 |
| Levy, D | 1 |
| Costa, RO | 1 |
| Zerbini, MCN | 1 |
| Rocha, V | 1 |
| Pereira, J | 1 |
| Kitamura, W | 1 |
| Kobayashi, H | 1 |
| Urata, T | 1 |
| Sato, Y | 1 |
| Naoi, Y | 1 |
| Yoshino, T | 2 |
| Maeda, Y | 2 |
| Kuyama, S | 1 |
| Li, W | 1 |
| Zhang, L | 2 |
| Huang, X | 1 |
| Feng, D | 1 |
| Zou, X | 1 |
| Zhou, Y | 1 |
| Hong, H | 1 |
| Fang, X | 1 |
| Huang, H | 3 |
| Wang, Z | 1 |
| Lin, T | 1 |
| Yao, H | 1 |
| Klebaner, D | 1 |
| Koura, D | 1 |
| Tzachanis, D | 1 |
| Ball, ED | 1 |
| Horwitz, S | 1 |
| Goodman, AM | 1 |
| Larroquette, M | 1 |
| Issa, N | 1 |
| Gabriel, F | 1 |
| Camou, F | 1 |
| Schmitz, N | 1 |
| Truemper, L | 1 |
| Bouabdallah, K | 1 |
| Ziepert, M | 1 |
| Leclerc, M | 1 |
| Cartron, G | 1 |
| Jaccard, A | 1 |
| Reimer, P | 1 |
| Wagner, E | 1 |
| Wilhelm, M | 1 |
| Sanhes, L | 1 |
| Lamy, T | 1 |
| de Leval, L | 1 |
| Rosenwald, A | 1 |
| Roussel, M | 1 |
| Kroschinsky, F | 1 |
| Lindemann, W | 1 |
| Dreger, P | 1 |
| Viardot, A | 1 |
| Milpied, N | 2 |
| Gisselbrecht, C | 1 |
| Wulf, G | 1 |
| Gyan, E | 1 |
| Gaulard, P | 1 |
| Bay, JO | 1 |
| Glass, B | 1 |
| Poeschel, V | 1 |
| Damaj, G | 1 |
| Sibon, D | 1 |
| Delmer, A | 1 |
| Bilger, K | 1 |
| Banos, A | 1 |
| Haenel, M | 1 |
| Dreyling, M | 1 |
| Metzner, B | 1 |
| Keller, U | 1 |
| Braulke, F | 1 |
| Friedrichs, B | 1 |
| Nickelsen, M | 1 |
| Altmann, B | 1 |
| Tournilhac, O | 1 |
| Zhang, Q | 1 |
| Liu, C | 1 |
| Liu, Z | 1 |
| Liu, M | 1 |
| Xie, C | 1 |
| Zheng, J | 1 |
| Han, C | 1 |
| Zhang, D | 1 |
| Zhang, J | 1 |
| Fu, S | 1 |
| Liu, J | 1 |
| Wang, Q | 1 |
| Jiang, Y | 1 |
| Zhu, Q | 1 |
| Duan, Y | 1 |
| Chen, X | 1 |
| Xu, T | 1 |
| Jin, Z | 1 |
| Li, C | 1 |
| Wu, D | 1 |
| Kida, S | 1 |
| Fuji, S | 1 |
| Morishima, T | 1 |
| Nakata, K | 1 |
| Miyashiro, I | 1 |
| Ishikawa, J | 1 |
| Li, L | 1 |
| Duan, W | 1 |
| Li, X | 1 |
| Fu, X | 1 |
| Wang, X | 1 |
| Wu, J | 1 |
| Sun, Z | 1 |
| Zhang, X | 1 |
| Chang, Y | 1 |
| Nan, F | 1 |
| Yan, J | 1 |
| Li, Z | 1 |
| Young, KH | 1 |
| Zhang, M | 1 |
| Kaito, S | 1 |
| Kanemasa, Y | 1 |
| Sasaki, Y | 1 |
| Okuya, T | 1 |
| Yamaguchi, T | 1 |
| Funasaka, C | 1 |
| Shimoyama, T | 1 |
| Omuro, Y | 1 |
| Hishima, T | 1 |
| Vu, K | 1 |
| Ai, W | 1 |
| Liu, X | 1 |
| Yang, M | 1 |
| Wu, M | 1 |
| Zheng, W | 1 |
| Xie, Y | 1 |
| Zhu, J | 1 |
| Song, Y | 1 |
| Liu, W | 1 |
| Janikova, A | 1 |
| Chloupkova, R | 1 |
| Campr, V | 1 |
| Klener, P | 1 |
| Hamouzova, J | 1 |
| Belada, D | 1 |
| Prochazka, V | 1 |
| Pytlik, R | 1 |
| Pirnos, J | 1 |
| Duras, J | 1 |
| Mocikova, H | 1 |
| Bortlicek, Z | 1 |
| Kopalova, N | 1 |
| Mayer, J | 1 |
| Trneny, M | 1 |
| Huh, SJ | 1 |
| Oh, SY | 1 |
| Lee, S | 1 |
| Lee, JH | 1 |
| Kim, SH | 1 |
| Lee, GW | 1 |
| Kim, SJ | 1 |
| Kim, WS | 1 |
| Lee, HS | 1 |
| Jo, JC | 1 |
| Kim, MJ | 1 |
| Kwon, JH | 1 |
| Kim, HJ | 1 |
| Salamoon, M | 1 |
| Bachour, M | 1 |
| Hussein, T | 1 |
| Kenj, M | 1 |
| Nakaji, K | 1 |
| Nakae, Y | 1 |
| Fujita, A | 1 |
| Kumamoto, M | 1 |
| Nakamura, Y | 2 |
| Muroya, D | 1 |
| Toh, U | 1 |
| Iwakuma, N | 1 |
| Nakagawa, S | 1 |
| Mishima, M | 1 |
| Takahashi, R | 1 |
| Takenaka, M | 1 |
| Shirouzu, K | 1 |
| Agaki, Y | 1 |
| Rattarittamrong, E | 1 |
| Norasetthada, L | 1 |
| Tantiworawit, A | 1 |
| Chai-Adisaksopha, C | 1 |
| Nawarawong, W | 1 |
| Ellin, F | 2 |
| Landström, J | 2 |
| Jerkeman, M | 2 |
| Relander, T | 2 |
| Coiffier, B | 1 |
| Federico, M | 1 |
| Caballero, D | 1 |
| Dearden, C | 1 |
| Morschhauser, F | 1 |
| Jäger, U | 1 |
| Trümper, L | 1 |
| Zucca, E | 1 |
| Gomes da Silva, M | 1 |
| Pettengell, R | 1 |
| Weidmann, E | 1 |
| d'Amore, F | 1 |
| Tilly, H | 1 |
| Zinzani, PL | 2 |
| Tomita, N | 2 |
| Hattori, Y | 1 |
| Fujisawa, S | 1 |
| Hashimoto, C | 1 |
| Taguchi, J | 1 |
| Takasaki, H | 1 |
| Sakai, R | 1 |
| Tateishi, U | 1 |
| Ishigatsubo, Y | 2 |
| Zhang, H | 1 |
| Kheradpour, A | 1 |
| Rowsell, EH | 1 |
| Zuppan, CW | 1 |
| Weiss, LM | 1 |
| Wang, J | 1 |
| Sekiguchi, Y | 1 |
| Shirane, S | 1 |
| Shimada, A | 1 |
| Ichikawa, K | 1 |
| Wakabayashi, M | 1 |
| Sugimoto, K | 1 |
| Tomita, S | 1 |
| Izumi, H | 1 |
| Nakamura, N | 2 |
| Sawada, T | 1 |
| Ohta, Y | 1 |
| Komatsu, N | 1 |
| Noguchi, M | 1 |
| Shibata, Y | 1 |
| Hara, T | 1 |
| Kasahara, S | 1 |
| Yamada, T | 1 |
| Sawada, M | 1 |
| Mabuchi, R | 1 |
| Matsumoto, T | 1 |
| Nakamura, H | 1 |
| Ninomiya, S | 1 |
| Kitagawa, J | 1 |
| Kanemura, N | 1 |
| Kito, Y | 1 |
| Goto, N | 1 |
| Miyazaki, T | 1 |
| Takami, T | 1 |
| Takeuchi, T | 1 |
| Shimizu, M | 1 |
| Tsurumi, H | 1 |
| Beaven, AW | 1 |
| Diehl, LF | 1 |
| Pileri, A | 1 |
| Pellegrini, C | 1 |
| Agostinelli, C | 1 |
| Grandi, V | 1 |
| Patrizi, A | 1 |
| Pimpinelli, N | 1 |
| Hirata, Y | 1 |
| Yokote, T | 1 |
| Kobayashi, K | 1 |
| Nakayama, S | 1 |
| Miyoshi, T | 1 |
| Akioka, T | 1 |
| Tsuji, M | 1 |
| Takubo, T | 1 |
| Hanafusa, T | 1 |
| Cunningham, S | 1 |
| Muneer, S | 1 |
| Ranganathan, A | 1 |
| Shrader, M | 1 |
| Hemmaway, C | 1 |
| Mian, A | 1 |
| Nagy, Z | 1 |
| Tucci, A | 1 |
| Cerqui, E | 1 |
| Ungari, M | 1 |
| Ferrari, S | 1 |
| Baushi, L | 1 |
| Facchetti, F | 1 |
| Rossi, G | 1 |
| Armitage, JO | 1 |
| Miyashita, K | 1 |
| Oshiro, H | 1 |
| Matsumoto, C | 1 |
| Nakajima, Y | 1 |
| Ito, S | 1 |
| Matsumoto, K | 1 |
| Fujita, H | 1 |
| Niitsu, N | 1 |
| Hayama, M | 1 |
| Nakamura, S | 1 |
| Tamaru, J | 1 |
| Nakamine, H | 2 |
| Okamoto, M | 1 |
| Advani, RH | 1 |
| Hong, F | 1 |
| Horning, SJ | 1 |
| Kahl, BS | 1 |
| Manola, J | 1 |
| Swinnen, LJ | 1 |
| Habermann, TM | 1 |
| Ganjoo, K | 1 |
| Chen, XG | 1 |
| Tian, Y | 1 |
| Guo, CC | 1 |
| Liang, CY | 1 |
| Gong, YL | 1 |
| Zou, BY | 1 |
| Cai, RQ | 1 |
| Lin, TY | 1 |
| Kawanishi, K | 1 |
| Ohyama, Y | 1 |
| Kanai, Y | 1 |
| Hirase, T | 1 |
| Tanaka, H | 1 |
| Miyatake, J | 1 |
| Tatsumi, Y | 1 |
| Ashida, T | 1 |
| Matsumura, I | 1 |
| Arai, H | 1 |
| Maki, K | 1 |
| Tadokoro, J | 1 |
| Handa, T | 1 |
| Tsurumi, S | 1 |
| Sasaki, K | 1 |
| Mitani, K | 1 |
| Uni, M | 1 |
| Yoshimi, A | 1 |
| Nakamura, F | 1 |
| Takazawa, Y | 1 |
| Fukayama, M | 1 |
| Kurokawa, M | 1 |
| Taguchi, A | 1 |
| Miyazaki, M | 1 |
| Sakuragi, S | 1 |
| Shinohara, K | 1 |
| Kamei, T | 1 |
| Inoue, Y | 1 |
| Schleinitz, N | 1 |
| Veit, V | 1 |
| Coso, D | 1 |
| Aurran, T | 1 |
| Berbis, P | 1 |
| Harle, JR | 1 |
| Haas, A | 1 |
| Lobeck, H | 1 |
| Hummel, M | 1 |
| Maschmeyer, G | 1 |
| Mahé, B | 1 |
| Gaillard, F | 1 |
| Labadie, F | 1 |
| Papin, S | 1 |
| Letortorec, S | 1 |
| Moreau, P | 1 |
| Harousseau, JL | 1 |
| Sohn, SK | 1 |
| Ahn, T | 1 |
| Kim, DH | 1 |
| Jung, JT | 1 |
| Hyun, DW | 1 |
| Lee, YH | 1 |
| Suh, CS | 1 |
| Lee, J | 1 |
| Lee, KB | 1 |
| Abe, Y | 1 |
| Ohshima, K | 1 |
| Shiratsuchi, M | 1 |
| Honda, K | 1 |
| Nishimura, J | 1 |
| Nawata, H | 1 |
| Muta, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Allo-allo Tandem Matched Stem Cell Transplantation (AATT) for the Treatment of Patients With Refractory Acute Leukemia; a Feasibility Phase I/II Study[NCT00984412] | Phase 1/Phase 2 | 15 participants (Anticipated) | Interventional | 2009-11-30 | Recruiting | ||
| A Randomized Controlled Multi-center Clinical Trial on Treatment of Peripheral T-cell Lymphoma With DGPT Regiment (Gemcitabine,Cisplatin,Prednisone ,Thalidomide )[NCT01664975] | Phase 4 | 100 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| Phase II Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma[NCT05996185] | Phase 2 | 36 participants (Anticipated) | Interventional | 2024-01-31 | Not yet recruiting | ||
| Nivolumab With Standard of Care Chemotherapy for the First Line Treatment of Peripheral T Cell Lymphoma[NCT03586999] | Phase 1/Phase 2 | 18 participants (Actual) | Interventional | 2018-11-07 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01664975)
Timeframe: up to end of follow-up-phase (approximately 24 months)
| Intervention | participants (Number) |
|---|---|
| GDPT Regimen | 35 |
| CHOP Regimen | 27 |
7 reviews available for prednisolone and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Update on the Treatment of Anaplastic Large Cell Lymphoma.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Ve | 2018 |
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemo | 2014 |
Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bone Marrow; Bone M | 2015 |
Improving therapy for patients with aggressive lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubi | 2011 |
Primary hepatic peripheral T-cell lymphoma treated with corticosteroid.
Topics: Adrenal Cortex Hormones; Aged; Humans; Liver Neoplasms; Lymphoma, T-Cell, Peripheral; Male; Predniso | 2011 |
[CD20-positive peripheral T-cell lymphoma, not otherwise specified].
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protoco | 2012 |
Gamma/delta T cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cyclophosphamide; DNA, Viral; Dox | 2004 |
3 trials available for prednisolone and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Topics: Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Ther | 2021 |
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplati | 2017 |
Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamid | 2011 |
37 other studies available for prednisolone and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income Country.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brazil; Cyclophosphamide; Doxorubicin; Etoposide; Fe | 2022 |
Benefit of prednisolone alone in nodal peripheral T-cell lymphoma with T follicular helper phenotype.
Topics: Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell, Peripheral; Male; Phenotype; Prednisolone; | 2023 |
A Case of Lung Involvement in Peripheral T Cell Lymphoma.
Topics: Acidosis, Lactic; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; D | 2019 |
The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2020 |
Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Induc | 2020 |
Atypical presentation of a central nervous system aspergillosis in a peripheral T cell lymphoma patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brown-Sequard Syndrome; Cyclophos | 2020 |
Esophageal peripheral T-cell lymphoma treated with radiotherapy: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aphasia; Cyclophosphamide; Doxorubicin; Esophagus; H | 2021 |
Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.
Topics: Adolescent; Adult; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Borte | 2021 |
Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2021 |
A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C | 2018 |
A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; | 2019 |
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclopho | 2019 |
The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scores.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Do | 2019 |
Treatment of peripheral T cell lymphoma with an intensive protocol ACEP (adriamycin, cyclophosphamide, etoposide and prednisolone) and ifosfamide showing an important response and overall survival rates.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fem | 2013 |
[A case of melena and perforation during chemotherapy for peripheral T-cell lymphoma, not otherwise specified of the small intestine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Intesti | 2013 |
Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine- | 2015 |
CHOEP-21 chemotherapy for newly diagnosed nodal peripheral T-cell lymphomas (PTCLs) in Maharaj Nakorn Chiang Mai Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Et | 2013 |
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort S | 2014 |
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort S | 2014 |
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort S | 2014 |
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort S | 2014 |
Post-therapy ¹⁸F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Do | 2015 |
Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.
Topics: Adult; Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combi | 2015 |
Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature.
Topics: Age of Onset; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; | 2015 |
CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Do | 2017 |
Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Fre | 2015 |
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dermat | 2017 |
Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumor lysis in a patient with peripheral T-cell lymphoma unspecified.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 2009 |
The 51st annual meeting of the American Society of Hematology.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Images in haematology. Irreversible blindness secondary to posterior reversible encephalopathy syndrome following CHOP combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Cyclophosphamide; Doxorubicin; Female; Hu | 2010 |
Continuous oral cyclophosphamide and prednisolone as a valuable treatment option for peripheral T cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dr | 2011 |
Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pro | 2012 |
Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 2011 |
Sub-acute demyelinating polyradiculoneuropathy as an initial symptom of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymph Nodes; | 2012 |
Successful allogeneic stem cell transplantation for Lennert lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow | 2013 |
Drug-induced eosinophilia and systemic symptoms: hypersensitivity or peripheral T-cell lymphoma?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Diagnosis, | 2005 |
[Prolonged remission after immunotherapy of a previously refractory peripheral T-cell non-Hodgkin lymphoma].
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antine | 2006 |
Occurrence of a T cell lymphoma in a patient with chronic myeloid leukemia treated with alpha interferon.
Topics: Anemia, Hemolytic, Autoimmune; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Pro | 1995 |
Hepatosplenic T-cell lymphoma: prolymphocytic transformation 18 months after splenectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Combined Modality | 1997 |
Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubi | 2001 |